Abstract Library

#3731 Rare metastases diagnosed on 68Ga-DOTATOC-PET/CT in small intestinal and pancreatic NETs

Introduction: Neuroendocrine metastases to the orbita, heart, breast, bone, Virchow's lymph node, and pancreas are rarely encountered in small intestinal (SI-NETs) and pancreatic NETs (P-NETs).

Conference:

Presenting Author: Wedin M

Authors: Wedin M, Daskalakis K, Wallin G, Sundin A, Tiensuu Janson E,

Keywords: Neuroendocrine Neoplasm, Rare metastases, Bone metastases, breast metastases, orbita metastases, heart metastases, Lung and pleural metastases, Pancreatic metastases,

#3677 Myelophthisis as an end-stage outcome of rare metastases in neuroendocrine tumors – A dual case report

Introduction: Intra-abdominal Neuroendocrine Tumors (NETs) usually metastasize to regional lymph nodes, liver, and bone. Myelophthisis (MPT) is the destruction of the medullary microenvironment due to the tumoral invasion of the trabecular space, altering normal hematopoiesis; it’s frequently caused by metastasis of breast, prostate, and lung adenocarcinomas, and neuroblastoma. MPT due to NET is an unrecognized phenomenon with few cases reported, almost exclusively in poorly differentiated NETs.

Conference:

Presenting Author:

Authors: González Devia D, Aldana-Gómez L, Segovia Gómez J, Ortiz-Santacruz C, Mejía-Arango M,

Keywords: Neuroendocrine Tumor, Myelophthisis, Colon tumor, Prostate tumor, End-stage,

#162 Different sites of rare metastases in neuroendocrine tumor patients detected by Ga-68 somatostatin receptor PET/CT

Introduction: The most common sites of metastases in neuroendocrine tumors are liver, lymph nodes, and bone.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Prasad V, Baum R,

Keywords: neuroendocrine tumors, rare sites of metastases, Ga-68 SMS-R PET/CT,